LivaNova (NASDAQ: LIVN) revenue
LivaNova reported revenue of $1,388m for fiscal 2025, 10.7% more than in fiscal 2024 ($1,253m). Since fiscal 2016 its revenue has grown by 43.9%, an average growth of 4.1% a year.
LivaNova has grown its revenue for 3 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −13.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1,388m | +10.7% | $199.4m | 14.4% |
| 2024 | $1,253m | +8.7% | $129.1m | 10.3% |
| 2023 | $1,154m | +12.9% | −$68.5m | −5.9% |
| 2022 | $1,022m | −1.3% | −$76.8m | −7.5% |
| 2021 | $1,035m | +10.8% | −$0.8m | −0.1% |
| 2020 | $934.2m | −13.8% | −$273.9m | −29.3% |
| 2019 | $1,084m | −2.1% | −$171.6m | −15.8% |
| 2018 | $1,107m | +9.4% | −$248.1m | −22.4% |
| 2017 | $1,012m | +4.9% | $96.5m | 9.5% |
| 2016 | $964.9m | — | $33.4m | 3.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
LivaNova revenue compared with its sector
By revenue for its latest fiscal year, LivaNova ranks 132nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; LivaNova, 10.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 130th | Penumbra | $1,404m | 17.5% |
| 131st | Halozyme Therapeutics | $1,397m | 37.6% |
| 132nd | LivaNova | $1,388m | 10.7% |
| 133rd | Conmed | $1,375m | 5.2% |
| 134th | Haemonetics | $1,334m | −2.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of LivaNova
- How much revenue did LivaNova make in fiscal 2025?
- LivaNova reported revenue of $1,388m for fiscal 2025, compared with $1,253m in fiscal 2024.
- How much has the revenue of LivaNova grown?
- Between fiscal 2016 and fiscal 2025 it went from $964.9m to $1,388m: 43.9% more, an average growth of 4.1% a year.
- What was the best year for revenue at LivaNova?
- Of its last 10 fiscal years, fiscal 2025, with $1,388m.
- Where does LivaNova rank in its sector by revenue?
- It ranks 132nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for LivaNova come from?
- From the annual report (Form 10-K) that LivaNova files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that LivaNova files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on LivaNova: the LivaNova page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.